B&L invests in presbyopia

Article

Bausch & Lomb has made an equity investment in AcuFocus.

Bausch & Lomb has made an equity investment in - and secures an exclusive option to purchase - AcuFocus, a privately held company in California, USA.

AcuFocus is developing a corneal inlay, the ACI 7000, for the treatment of presbyopia. The inlay is implanted in the cornea under a LASIK flap and incorporates technology that increases a patient's depth of field, thereby improving near vision. The procedure involves no tissue removal and does not permanently alter the cornea, so pre-implant vision can be restored should the inlay be removed. Terms of the agreement were not disclosed.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
Related Content
Rows of medical syringes in sanitary packaging. Concept image for aflibercept intravitreal eye injection. ©Titolino – stock.adobe.com

Study examines real-world treat-and-extend outcomes and background factors of macular atrophy

Lynda Charters
March 21st 2025
Article

The study demonstrated that the number of injections needed gradually decreased during the follow-up period

Higher molar dose and its translation into clinical practice. Led by John Kitchens, MD; Joined by Peter Kaiser, MD

Higher Molar Dose and Its Translation into Clinical Practice

John Kitchens, MD;Peter Kaiser, MD
July 22nd 2024
Podcast
A blue hazard sign, an exclamation point (!) inside a triangle, to communicate the risks of misdiagnosing geographic atrophy and age-related macular degeneration. Image credit: ©jcsnb – stock.adobe.com

Researchers raise awareness of macular pathologies which mimic AMD and GA

Lynda Charters
March 20th 2025
Article

Inherited retinal diseases have disease processes distinct from age-related macular degeneration and geographic atrophy, but may present with "phenocopy" clinical signs

From left: Maria Vittoria Cicinelli, MD; Denise Loya-Garcia, MD, PhD; Vishal Raval, MD. Images courtesy of ARVO.

Three researchers receive 2025 ARVO Foundation Early Career Clinician-Scientist Awards

Martin David Harp
March 18th 2025
Article

The award recipients are leading research projects in India, Italy and Mexico

A woman stands at a mirror, inserting a contact lens. Image credit: ©Camerene Pendl/peopleimages.com – stock.adobe.com

Bausch + Lomb launches Arise orthokeratology lens fitting system in Europe, UK and US

Jordana Joy
March 17th 2025
Article

The Arise system utilises advanced algorithms to interpret corneal topography images, recommending lenses without requiring a fitting set

Images of a chest X-ray and a CT scan show the chest and vascular system following a COVID-19 infection. Image credit: ©samunella – stock.adobe.com

EDI-OCT and CVI findings can shed light on choroidal vascular physiology following COVID-19 pneumonia

Lynda Charters
March 17th 2025
Article

Investigators measured the choroidal structures using enhanced depth imaging optical coherence tomography

© 2025 MJH Life Sciences

All rights reserved.